CTN :43161610
07 Jan, 2026
NA
Tender For e-tender for the procurement of specialty drugs for the year 2026-27 - acyclovir intravenous infusion ip 500 mg, acyclovir tab ip 800 mg, adenosine inj ip 3 mg/ml, alteplase inj 50 mg, amphotericin b inj ip 50 mg/ml, amphotericin b liposomal inj 50 mg, ampicillin and sulbactam for inj each vial contains ampicillin 1 g and sulbactam 0.5 g, aripiprazole tab ip 10 mg, artesunate +(sulphadoxine + pyremethamine) each combi blister pack contains; [3 tablets of artesunate (each 200 mg) and 2 tablets of sulphadoxine + pyremethamine (each 750 mg + 37.5 mg)] or [3 tablets of artesunate (each 200 mg) and 3 tablets of sulphadoxine + pyremethamine (each 500 mg + 25 mg)], artesunate inj ip 60 mg, atomoxetine tab 10 mg, atomoxetine tab 25 mg, aztreonam inj usp 1 gm, barium sulphate suspension bp/usp 95% w/v, bethanechol chloride tab bp 25 mg, an cl
ass="text-red-selected">botulinuman>
an class="text-red-selected">toxinan>
a inj (freeze-dried powder for
injection) 50 units,
an class="text-red-selected">botulinuman>
an class="text-red-selected">toxinan>
a inj (freeze-dried powder for
injection) 100 units, c
affeine citr
ate
inj bp/usp 20 mg/ml, c
alcitriol t
ab 0.25 mcg, c
alcium
acet
ate t
ab 667 mg, c
arbim
azole t
ab ip 5 mg, cefpodoxime or
al suspension ip 100 mg/5 ml, ceft
azidime
and
avib
act
am
inj e
ach vi
al cont
ains ceft
azidime pent
ahydr
ate equiv
alent to ceft
azidime 2 g
and
avib
act
am sodium equiv
alent to
avib
act
am 0.5 g, ceft
azidime for
inj ip 1 gm, cefuroxime
axetil t
ab ip 500 mg, citicoline
inj ip 500 mg, cl
arithromycin t
ab ip 500 mg, clind
amycin c
ap ip 300 mg, clind
amycin gel 1%, clobet
asol propion
ate + s
alicylic
acid ointment 0.05% w/w + 3.00% w/w, clopidogrel+
aspirin t
ab ip 75 mg + 75 mg, colistimeth
ate
inj ip 3 miu, cyclosporine c
ap ip 100 mg, d
abig
atr
an c
ap 110 mg, d
ap
agliflozin t
ab 10 mg, d
apsone t
ab ip 100 mg, d
arifen
acin t
ab 7.5 mg, desonide lotion 0.05%, dicum
arol t
ab 25 mg, digoxin p
aedi
atric solution ip 50 mcg/ml, disodium hydrogen citr
ate syrup 1.53 gm/5 ml, div
alproex sodium prolonged rele
ase t
ab ip 500 mg, doxycycline
inj 100 mg, d-penicill
amine c
ap usp 250 mg, dut
asteride c
ap ip 0.5 mg, dydrogesterone t
ab ip 10 mg, entec
avir t
ab ip 0.5 mg, esmolol
inj ip 10 mg/ml, eth
amsyl
ate
inj 125 mg/ml, ethinyl oestr
adiol
and cyproterone
acet
ate t
ab 35 mcg+ 2 mg, etomid
ate
inj usp 2 mg/ml, fexofen
adine t
ab ip 120 mg, fin
asteride t
ab ip 5 mg, fl
avox
ate t
ab ip 200 mg, flucon
azole infusion bp 200 mg/100 ml, fluoxetine c
ap ip 10 mg, flupenthixol
inj ip 20 mg/ml, flutic
asone cre
am ip 0.05% w/w, flutic
asone furo
ate n
as
al spr
ay 27.5 mcg, fluvox
amine t
ab ip 100 mg, formoterol fum
ar
ate
and budesonide inh
aler 6 mcg + 200 mcg, fosphenytoin
inj e
ach ml cont
ains; fosphenytoin sodium 75 mg equiv
alent to phenytoin sodium 50 mg, fr
amycetin skin cre
am 1% w/w, g
adoben
ate dimeglumine
inj 529 mg/ml, gent
amicin + clotrim
azole + beclometh
asone cre
am 0.1% + 1% + 0.025%, glicl
azide t
ab 40 mg, hcg (hum
an chorionic gon
adotropin)
inj ip 5000 iu, hep
atitis b v
accine (rdn
a) ip 20 mcg, hum
an
albumin
inj ip 20%, hum
an norm
al immunoglobulin for intr
avenous use ip 5 gm, hy
aluronid
ase
inj ip 1500 u, hydrocortisone cre
am ip 1%, hydroxy progesterone c
apro
ate
inj ip 250 mg/ml, isopren
aline
inj ip 2 mg/ml, itr
acon
azole t
ab 200 mg, iv
abr
adine t
ab 5 mg, l ornithine l
asp
art
ate infusion 5 gm/10 ml, l
acos
amide t
ab 100 mg, l
actulose enem
a 20% w/v, l
amivudine t
ab ip 100 mg, levetir
acet
am
inj 100 mg/ml, levetir
acet
am or
al solution ip 100 mg/ml, levoflox
acin infusion ip 500 mg, lignoc
aine + priloc
aine cre
am ip 2.5% + 2.5%, lignoc
aine hydrochloride topic
al solution ip 2% w/v, lignoc
aine spr
ay 10%, linezolid for or
al suspension 100 mg/5 ml, mecob
al
amine t
ab 500 mcg, medroxy progesterone
acet
ate depot
inj 150 mg/ml, menotropin for
injection (hmg -hum
an menop
aus
al gon
adotropin) ip/bp 75 iu, mephentermine
inj ip 30 mg/ml, methylphenid
ate t
ab 10 mg, methylprednisolone t
ab ip 8 mg, metoprolol
inj ip 1 mg/ml, mirt
az
apine t
ab ip 15 mg, misoprostol t
ab ip 100 mcg, misoprostol t
ab ip 25 mcg, momet
asone furo
ate cre
am ip 0.1% w/w, mycophenol
ate mofetil t
ab ip 500 mg, n
atur
al micronised progesterone
inj 100 mg/ml, n
atur
al surf
act
a